Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Sc16ld6.5
2. Sc-002
3. Sc002
1. Rova-t
2. Rovalpituzumab-tesirin
3. Unii-p256hb60ff
4. Rovalpituzumab Tesirine [inn]
5. P256hb60ff
6. Rovalpituzumab Tesirine [who-dd]
7. Sc002
8. Rovalpituzumab Tesirine [usan:inn]
9. Sc0002
10. 1613313-09-9
| Molecular Weight | 1617.8 g/mol |
|---|---|
| Molecular Formula | C78H108N10O25S |
| XLogP3 | -1.6 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 28 |
| Rotatable Bond Count | 53 |
| Exact Mass | 1616.72078014 g/mol |
| Monoisotopic Mass | 1616.72078014 g/mol |
| Topological Polar Surface Area | 456 Ų |
| Heavy Atom Count | 114 |
| Formal Charge | 0 |
| Complexity | 3190 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of lung carcinoma (small cell and non-small cell carcinoma)
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Rovalpituzumab Tesirine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rovalpituzumab Tesirine, including repackagers and relabelers. The FDA regulates Rovalpituzumab Tesirine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rovalpituzumab Tesirine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Rovalpituzumab Tesirine supplier is an individual or a company that provides Rovalpituzumab Tesirine active pharmaceutical ingredient (API) or Rovalpituzumab Tesirine finished formulations upon request. The Rovalpituzumab Tesirine suppliers may include Rovalpituzumab Tesirine API manufacturers, exporters, distributors and traders.
Rovalpituzumab Tesirine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rovalpituzumab Tesirine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rovalpituzumab Tesirine GMP manufacturer or Rovalpituzumab Tesirine GMP API supplier for your needs.
A Rovalpituzumab Tesirine CoA (Certificate of Analysis) is a formal document that attests to Rovalpituzumab Tesirine's compliance with Rovalpituzumab Tesirine specifications and serves as a tool for batch-level quality control.
Rovalpituzumab Tesirine CoA mostly includes findings from lab analyses of a specific batch. For each Rovalpituzumab Tesirine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rovalpituzumab Tesirine may be tested according to a variety of international standards, such as European Pharmacopoeia (Rovalpituzumab Tesirine EP), Rovalpituzumab Tesirine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rovalpituzumab Tesirine USP).
LOOKING FOR A SUPPLIER?
